About Keith Miller
Keith Miller is a chief technology officer (cto) and director at Hexamer Therapeutics.
Keith Miller first appears on SEC filings in 2019.
Experience
This experience comes from Keith Miller's profile and from SEC filings. For roles taken from filings, the years are when the filings name Keith Miller in the role, so the role may have started earlier or lasted longer.
Hexamer Therapeutics, Inc Current
Chief Technology Officer (CTO) and director
Chief Technology Officer and Co-Founder (2019 – Present)
2019 – Present · Pullman, WA
Develops vaccine technologies for human cancer and infectious diseases and for animal health companies.
AL
Affinogen Bioscience, LLC
President and Principal Scientist
2013 – 2020
AE
Amplicon Express
Scientist
2016 – 2019
TC
TRIA Bioscience Corporation
Principal Scientist
2012 – 2013
PL
Pacific Northwest National Laboratory
Senior Research Scientist IV
2003 – 2012
AI
AltaGen Biosciences Inc.
Research Scientist
2002
WB
Washington State University-School of Molecular Biosciences
Postdoctoral Research Associate
1999 – 2002
WU
Washington State University
Graduate Research Assistant
1995 – 1999
Key Colleagues at Startups
The people Keith Miller works with at each company, as listed on that company's latest Form D.
Hexamer Therapeutics, Inc · Form D, Sep 15, 2026
Robert Bogden
Chief Executive Officer (CEO) and director
BC
Brad Call
Director
RB
R. Scott Blackley
Director
CC
Colin Collins
Chief Scientific Officer and Co-Founder, director
SC
Stephen Crawford
Director